1-8 of 8
Bing Z. Carter, Ph.D
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

ARC Is Regulated by MAPK and PI3K and Confers Drug Resistance and Survival Advantage to AML in Vitro and in Vivo

Po Yee Mak, M.S., Duncan H Mak, M.S., Yuexi Shi, Vivian Ruvolo, Rodrigo Jacamo, Ph.D, Michael Andreeff, MD, PhD, Bing Z Carter, Ph.D
Journal: Blood
Blood (2012) 120 (21): 893.
https://doi.org/10.1182/blood.V120.21.893.893
Published: 2012
Journal Articles

Apoptosis Repressor with Caspase Recruitment Domain Is Regulated by the cIAP1-NIK Axis and Confers Resistance to SMAC Mimetic Birinapant-Induced Cell Death in AML

Bing Z. Carter, Ph.D, Po Yee Mak, M.S., Duncan H. Mak, M.S., Vivian Ruvolo, Rodrigo Jacamo, Ph.D, Steven M. Kornblau, MD, PhD, Michael Andreeff, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 534.
https://doi.org/10.1182/blood.V120.21.534.534
Published: 2012
Journal Articles

Apoptosis Repressor with Caspase Recruitment Domain (ARC) Increases AML Cell Migration and Adhesion in Vitro and in Vivo by Regulating Leukemia-Stroma Interactions.

Bing Z Carter, Ph.D, Po Yee Mak, M.S., Ye Chen, PhD, Rodrigo Jacamo, Ph.D, Vivian Ruvolo, Duncan H Mak, M.S., Teresa McQueen, Marina Konopleva, MD, PhD, Steven M. Kornblau, MD, PhD, Michael Andreeff, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 2626.
https://doi.org/10.1182/blood.V120.21.2626.2626
Published: 2012
Journal Articles

Survivin Is Highly Expressed in AML Stem Cells and Predicts Poor Clinical Outcome

Bing Z Carter, Ph.D., Yihua Qiu, Xielin Huang, PhD, Lixia Diao, PhD, Nianxiang Zhang, Kevin R Coombes, Duncan H Mak, M.S., Marina Konopleva, MD, PhD, Jorge E. Cortes, Hagop M. Kantarjian, Michael Andreeff, M.D., Ph.D., Steven M. Kornblau, MD
Journal: Blood
Blood (2011) 118 (21): 238.
https://doi.org/10.1182/blood.V118.21.238.238
Published: 2011
Journal Articles

Antagonizing IAPs by SMAC Mimetic TL32711 Induces Apoptosis in AML Cells Including AML Stem/Progenitor Cells Alone and in Combination with Chemotherapy

Bing Z Carter, Ph.D., Duncan H Mak, M.S., Yihua Qiu, Steven M. Kornblau, MD, Po Yee Mak, MS, David Weng, Mark A McKinlay, Michael Andreeff, M.D., Ph.D.
Journal: Blood
Blood (2011) 118 (21): 66.
https://doi.org/10.1182/blood.V118.21.66.66
Published: 2011
Journal Articles

MRx102, a Novel Triptolide Analogue, Has Low Nanomolar Activity Against AML Stem/Progenitor Cells in Vitro and in a Murine Model of AML

Bing Z Carter, Ph.D., Duncan H Mak, M.S., Yuxie Shi, John M. Fidler, Ph.D., Rong Chen, PhD, Xiaoyang Ling, PhD, William Plunkett, PhD, Michael Andreeff, M.D., Ph.D.
Journal: Blood
Blood (2011) 118 (21): 1547.
https://doi.org/10.1182/blood.V118.21.1547.1547
Published: 2011
Journal Articles

SMAC-Mimetic BV-6 Sensitizes Therapeutic Agents-Induced Apoptosis In AML Cells

Duncan H Mak, M.S., Christa Manton, Michael Andreeff, MD, PhD, Bing Z Carter, Ph.D.
Journal: Blood
Blood (2010) 116 (21): 2177.
https://doi.org/10.1182/blood.V116.21.2177.2177
Published: 2010
Journal Articles

Triptolide-Induced Apoptosis Is Dependent on Caspase Activation and NFκB Signaling and Mediated by XIAP and Survivin Downregulation through the Mitochondrial Pathway in Leukemic Cells.

Bing Z. Carter, Ph.D., Wendy D. Schober, Teresa McQueen, Randall L. Evans, Ph.D., Michael Andreeff, M.D., Ph.D.
Journal: Blood
Blood (2004) 104 (11): 3394.
https://doi.org/10.1182/blood.V104.11.3394.3394
Published: 2004